Literature DB >> 19272439

Cognitive deficits in interleukin-10-deficient mice after peripheral injection of lipopolysaccharide.

Amy F Richwine1, Nathan L Sparkman, Ryan N Dilger, Jessica B Buchanan, Rodney W Johnson.   

Abstract

Interleukin (IL)-10 is important for regulating inflammation but whether it protects against infection-related deficits in cognitive function is unknown. Therefore, the current study evaluated sickness behavior, hippocampal-dependent matching-to-place performance and several inflammatory cytokines and neurotrophins in wild-type (IL-10(+/+)) and IL-10-deficient (IL-10(-/-)) mice after i.p. injection of lipopolysaccharide (LPS). Additionally, morphology of dendrites of pyramidal neurons in the dorsal CA1 hippocampus was assessed. Treatment with LPS increased IL-1beta, IL-6, and tumor necrosis factor alpha (TNFalpha) mRNA in all brain areas examined including the hippocampus, in both IL-10(+/+) and IL-10(-/-) mice but the increase was largest in IL-10(-/-) mice. Plasma IL-1beta, IL-6 and TNFalpha were also higher in IL-10(-/-) mice compared to IL-10(+/+) mice after LPS. Consistent with increased inflammatory cytokines in IL-10(-/-) mice after LPS treatment, were a more lengthy sickness behavior syndrome and a more prominent reduction in hippocampal levels of nerve growth factor mRNA; brain-derived neurotrophic factor mRNA was reduced similarly in both genotypes after LPS. In a test of hippocampal-dependent learning and memory that required mice to integrate new information with previously learned information and switch strategies to master a task, IL-10(-/-) mice were found to be less efficient after LPS than were similarly treated wild-type mice. LPS did not affect morphology of dendrites of pyramidal neurons in the dorsal CA1 hippocampus in either genotype. Taken together the results are interpreted to suggest that during peripheral infection IL-10 inhibits sickness behavior and tribulations in hippocampal-dependent working memory via its propensity to mitigate inflammation. We conclude that IL-10 is critical for maintaining normal neuro-immune communication during infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19272439      PMCID: PMC2881543          DOI: 10.1016/j.bbi.2009.02.020

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  50 in total

1.  Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis.

Authors:  B A de Jong; H M Schrijver; T W Huizinga; E L Bollen; C H Polman; B M Uitdehaag; M C Kersbergen; A Sturk; R G Westendorp
Journal:  Ann Neurol       Date:  2000-10       Impact factor: 10.422

2.  Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease.

Authors:  C Holmes; M El-Okl; A L Williams; C Cunningham; D Wilcockson; V H Perry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

3.  Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats.

Authors:  Adriana B Silva-Gómez; Darío Rojas; Ismael Juárez; Gonzalo Flores
Journal:  Brain Res       Date:  2003-09-05       Impact factor: 3.252

4.  An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice.

Authors:  S M Ye; R W Johnson
Journal:  Neuroimmunomodulation       Date:  2001       Impact factor: 2.492

Review 5.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 6.  The immune system and memory consolidation: a role for the cytokine IL-1beta.

Authors:  C Rachal Pugh; M Fleshner; L R Watkins; S F Maier; J W Rudy
Journal:  Neurosci Biobehav Rev       Date:  2001-01       Impact factor: 8.989

Review 7.  Interleukin-10 in the brain.

Authors:  K Strle; J H Zhou; W H Shen; S R Broussard; R W Johnson; G G Freund; R Dantzer; K W Kelley
Journal:  Crit Rev Immunol       Date:  2001       Impact factor: 2.214

8.  Increased tumor necrosis factor and interleukin-6 production in the central nervous system of interleukin-10-deficient mice.

Authors:  D Agnello; P Villa; P Ghezzi
Journal:  Brain Res       Date:  2000-06-30       Impact factor: 3.252

9.  Exacerbated fatigue and motor deficits in interleukin-10-deficient mice after peripheral immune stimulation.

Authors:  C P Krzyszton; N L Sparkman; R W Grant; J B Buchanan; S R Broussard; J Woods; R W Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-23       Impact factor: 3.619

10.  Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus.

Authors:  Ruth M Barrientos; Emily A Higgins; David B Sprunger; Linda R Watkins; Jerry W Rudy; Steven F Maier
Journal:  Behav Brain Res       Date:  2002-08-21       Impact factor: 3.332

View more
  43 in total

Review 1.  Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences.

Authors:  Elissa J Donzis; Natalie C Tronson
Journal:  Neurobiol Learn Mem       Date:  2014-08-21       Impact factor: 2.877

2.  Treatment with Histone Deacetylase Inhibitor Attenuates Peripheral Inflammation-Induced Cognitive Dysfunction and Microglial Activation: The Effect of SAHA as a Peripheral HDAC Inhibitor.

Authors:  Naoki Takada; Yoki Nakamura; Keisuke Ikeda; Naoki Takaoka; Kazue Hisaoka-Nakashima; Seigo Sanoh; Yaichiro Kotake; Yoshihiro Nakata; Norimitsu Morioka
Journal:  Neurochem Res       Date:  2021-06-03       Impact factor: 3.996

3.  Integrative Analysis of Disease Signatures Shows Inflammation Disrupts Juvenile Experience-Dependent Cortical Plasticity.

Authors:  Milo R Smith; Poromendro Burman; Masato Sadahiro; Brian A Kidd; Joel T Dudley; Hirofumi Morishita
Journal:  eNeuro       Date:  2017-01-18

4.  Characterization of the Hippocampal Neuroimmune Response to Binge-Like Ethanol Consumption in the Drinking in the Dark Model.

Authors:  Isabella R Grifasi; Scot E McIntosh; Rhiannon D Thomas; Donald T Lysle; Todd E Thiele; S Alex Marshall
Journal:  Neuroimmunomodulation       Date:  2019-01-09       Impact factor: 2.492

5.  Air pollution impairs cognition, provokes depressive-like behaviors and alters hippocampal cytokine expression and morphology.

Authors:  L K Fonken; X Xu; Z M Weil; G Chen; Q Sun; S Rajagopalan; R J Nelson
Journal:  Mol Psychiatry       Date:  2011-07-05       Impact factor: 15.992

6.  Critical role for peripherally-derived interleukin-10 in mediating the thermoregulatory manifestations of fever and hypothermia in severe forms of lipopolysaccharide-induced inflammation.

Authors:  Lois M Harden; Christoph Rummel; Helen P Laburn; Jelena Damm; Florian Wiegand; Stephen Poole; Rüdiger Gerstberger; Joachim Roth
Journal:  Pflugers Arch       Date:  2013-10-10       Impact factor: 3.657

Review 7.  Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

8.  Cognitive impairment effects of early life stress in adolescents can be predicted with early biomarkers: Impacts of sex, experience, and cytokines.

Authors:  Rodrigo Grassi-Oliveira; Jennifer A Honeycutt; Freedom H Holland; Prabarna Ganguly; Heather C Brenhouse
Journal:  Psychoneuroendocrinology       Date:  2016-04-30       Impact factor: 4.905

9.  Cognitive dysfunction with aging and the role of inflammation.

Authors:  Arthur A Simen; Kelly A Bordner; Mark P Martin; Lawrence A Moy; Lisa C Barry
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

10.  A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.

Authors:  Meredith Hay; Robin Polt; Michael L Heien; Todd W Vanderah; Tally M Largent-Milnes; Kathleen Rodgers; Torsten Falk; Mitchell J Bartlett; Kristian P Doyle; John P Konhilas
Journal:  J Pharmacol Exp Ther       Date:  2019-02-01       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.